Filing Details

Accession Number:
0001439222-22-000009
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-02-16 17:00:33
Reporting Period:
2022-02-14
Accepted Time:
2022-02-16 17:00:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1439222 Agios Pharmaceuticals Inc. AGIO Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1874199 Jr. James Theodore Washburn 88 Sidney Street
Cambridge MA 02139
Principal Accounting Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-02-14 360 $0.00 3,413 No 4 M Direct
Common Stock Disposition 2022-02-14 127 $30.50 3,286 No 4 F Direct
Common Stock Disposition 2022-02-14 504 $31.25 2,782 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted stock units Disposition 2022-02-14 360 $0.00 360 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
360 No 4 M Direct
Footnotes
  1. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
  2. Includes 34 shares purchased through the Company's employee stock purchase plan.
  3. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  4. The restricted stock units were granted on February 14, 2020. Beginning on February 14, 2021, the shares underlying the restricted stock units will vest in three equal annual installments.